In vivo preclinical imaging: An essential tool in translational research

Drug Discovery World

Volumn 12, Issue 3, 2011, Pages 58-71

  Comley, John ^a  

^a HTStec Limited   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRIGHTSITE; CONTRAST MEDIUM; FERATRACK; FLUORESCENT DYE; FLUORINE 18; GLOSENSOR; IRDYE 680RD; IRDYE 800CW; LUCIFERASE; LUCIFERIN; SUPERPARAMAGNETIC IRON OXIDE; TRACER; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; VISCOVER;

ALGORITHM; BIOLUMINESCENCE; BIOSENSOR; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; EXPERIMENTAL ANIMAL; FLUORESCENCE; HUMAN; IMAGE PROCESSING; IMAGE QUALITY; IMAGE RECONSTRUCTION; IMAGING; IN VIVO STUDY; LASER; MOLECULAR IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL IMAGING; TRANSLATIONAL RESEARCH; X RAY;

EID: 79960982093     PISSN: 14694344     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (2)

1. In Vivo Preclinical Imaging Trends 2011 Report, published by HTStec Limited, Cambridge, UK, January 2011.
2. Galbán, S et al (2011). Imaging caspase dependent cell death as a surrogate for efficacy of cancer therapeutics. AACR Annual Meeting, Abstract #:LB-334.